Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.01 is 14% above its 5-year average of 1.77, near the low end of its 5-year range (0.21–6.82).
As of the fiscal period ended Tuesday, June 30, 2026. 8.17% above its 12-month average of 1.86.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.01.
QUICK RATIO (ACID-TEST)
2.01
QUICK RATIO (ACID-TEST) AVG TTM
1.86
QUICK RATIO (ACID-TEST) AVG 3Y
1.13
QUICK RATIO (ACID-TEST) AVG 5Y
1.77
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.17%
CURRENT VS 3Y AVG
+78.02%
CURRENT VS 5Y AVG
+13.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 567 covered companies
CURRENT VS SECTOR MEDIAN
-32.77%
vs the sector median at left
Ernexa Therapeutics Inc.
Market Cap
$4.34M
Quick Ratio (Acid-Test)
2.01
TTM Avg
1.86
3Y Avg
1.13
5Y Avg
1.77
Market Cap
$4.43M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.55M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$4.65M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
Market Cap
$4.01M
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.77
3Y Avg
2.83
5Y Avg
2.68
Market Cap
$4.75M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.83M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$4.96M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $4.34M | 2.01 | 1.86 | 1.13 | 1.77 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | 1.35 | 3.30 | 6.18 | 6.77 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 2.73 | 3.29 | 4.75 | 4.47 |
| GRI Bio, Inc. (GRI)vs › | $4.13M | 10.30 | 3.34 | 1.98 | 1.38 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.65M | 1.95 | 2.83 | 3.75 | 3.40 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.01M | 2.08 | 2.77 | 2.83 | 2.68 |
| CalciMedica, Inc. (CALC)vs › | $4.75M | 5.58 | 4.46 | 3.04 | 7.15 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.83M | 10.60 | 4.75 | 13.37 | 23.75 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.96M | 7.22 | 2.13 | 2.10 | 5.04 |
| Eocene Ltd. (EOCN)vs › | $3.70M | N/A | N/A | N/A | N/A |
Quick Ratio
2.01
Excludes inventory
Current Ratio
2.01
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.01 |
| 2026-03-31 | 2.89 |
| 2025-12-31 | 1.01 |
| 2025-09-30 | 1.58 |
| 2025-06-30 | 1.81 |
| 2025-03-31 | 0.21 |
| 2024-12-31 | 0.80 |
| 2024-09-30 | 0.48 |
| 2024-06-30 | 0.37 |
| 2024-03-31 | 0.79 |
| 2023-12-31 | 1.46 |
| 2023-09-30 | 0.73 |
| 2023-06-30 | 0.54 |
| 2023-03-31 | 1.21 |
| 2022-12-31 | 1.79 |
| 2022-09-30 | 2.12 |
| 2022-06-30 | 3.08 |
| 2022-03-31 | 6.82 |
| 2021-12-31 | 5.10 |
| 2021-09-30 | 5.65 |
| 2021-06-30 | 6.76 |
| 2021-03-31 | 2.23 |
| 2020-12-31 | 0.55 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
